Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Torrent Pharmaceuticals Ltd.

www.torrentpharma.com

Latest From Torrent Pharmaceuticals Ltd.

Torrent Outlook Muted On COVID-19

After a tepid performance in the fiscal fourth quarter, Torrent expects its key markets India, US and Brazil to be impacted by the COVID-19 fallout as well as a lack of visibility on regulatory approvals for its manufacturing facilities.

Strategy Sales & Earnings

Torrent Outlook Muted On COVID-19, Regulatory Concerns

After a tepid performance in the fiscal fourth quarter, Torrent expects its key markets India, US and Brazil to be impacted by the COVID-19 fallout as well as a lack of visibility on regulatory approvals for its manufacturing facilities.

Commercial Sales & Earnings

Indian Firms Take Different Paths On Ranitidine

A double blow to ranitidine medicines  suspension in the EU and a withdrawal request in the US  has caused Indian API and formulation manufacturers to recalibrate their strategies. Amid uncertainty over future prospects for the gastrointestinal drug, Strides is considering a relaunch in the US while Solara is reassigning part of its capacity to manufacture other APIs.

Strategy Generic Drugs

Ranitidine Blow Sees Indian Firms Take Different Paths

A double blow to ranitidine medicines - suspension in the EU and a withdrawal request in the US - has caused Indian API and formulation manufacturers to recalibrate their strategies. Amid uncertainty over future prospects for the gastrointestinal drug, Strides is considering a relaunch in the US while Solara is reassigning part of its capacity to manufacture other APIs.

Commercial Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Torrent Pharmaceuticals Ltd.
  • Senior Management
  • Sudhir Mehta, Chmn.
  • Contact Info
  • Torrent Pharmaceuticals Ltd.
    Phone: (91) 79-26599000
    Torrent House, Off. Ashram Rd.
    Ahmedabad, 380 009
    India
UsernamePublicRestriction

Register